Cargando…
Are patients more adherent to newer drugs?
The annual preventable cost from non-adherence in the US health care system amounts to $100 billion. While the relationship between adherence and the health system, the condition, patient characteristics and socioeconomic factors are established, the role of the heterogeneous productivity of drug tr...
Autores principales: | Blankart, Katharina E., Lichtenberg, Frank R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674371/ https://www.ncbi.nlm.nih.gov/pubmed/32770286 http://dx.doi.org/10.1007/s10729-020-09513-5 |
Ejemplares similares
-
Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less
por: Flory, James H, et al.
Publicado: (2021) -
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
Drug resistance in leishmaniasis: Newer developments
por: Mohapatra, Sarita
Publicado: (2014) -
Newer drug delivery systems in anesthesia
por: Dave, Sona, et al.
Publicado: (2017) -
Newer antidiabetic drugs and calorie restriction mimicry
por: Kalra, Sanjay, et al.
Publicado: (2016)